Go to Page # Page of 3

Atosiban

 Atosiban
  9th-Oct-2018
Description: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.
Important Tags: Atosiban
Views: 2004
Domain: Business
Category: Companies

Recent Presentations

...
23 February, 2019
CIOLOOK
22 February, 2019

Innovative Procurement

Procurement of solutions new to the market where the public sector acts as first customer.

...
22 February, 2019